24 September, 2026 | Jabbar Ali - MPharm
If you're using Wegovy injections and you've heard there's now a pill version, you might be wondering whether the switch is worth making. It's a fair question, and you're not the only one asking it.
The reassuring part is that moving from the injection to the Wegovy Pill is often possible, because you'd be staying on the same medicine.
In this article, we explain how the switch works, what changes day to day, and when it might, or might not, be right for you.
For most people, yes. This is one of the more straightforward switches, because you're not changing to a different medicine.
Both the Wegovy (Semaglutide) injection and the Wegovy Pill contain the same active ingredient, Semaglutide. You wouldn't be stopping treatment. You'd simply be changing how the medicine reaches your body.
The difference is in how it's absorbed:
Because of this, many people can take their first pill around the time their next injection would have been due, then continue with a pill each day.
Your prescriber will confirm the timing and the right strength for you, as this depends on your current dose and how well you're getting on with treatment.
“It's a real positive that patients now have a pill option alongside the injection. More choice means we can shape treatment around someone's routine and preferences, not only their clinical needs. What matters most is that any switch is the right one for the individual, and that's always a conversation to have with our clinical team.”
Omar El-Gohary, CEO and Superintendent Pharmacist, iQ Doctor
You won't usually start again from the lowest dose, because your body is already used to Semaglutide.
That said, the injection and the pill are absorbed differently, so there isn't a simple milligram-for-milligram match. Your prescriber chooses the closest suitable pill strength based on your current injection dose:
How you're tolerating treatment matters too. If you're finding side effects difficult at your current dose, your prescriber may suggest a lower pill strength to begin with, rather than the closest match.
The aim is a dose that works and feels manageable for you.
Thinking about the pill?
You can find out more on our Wegovy Pill page, or speak to our UK-based clinical team about whether switching suits you.
Because you're continuing with Semaglutide rather than stopping, switching isn't expected to cause your weight to climb back up.
Both forms of the medicine have been shown to support meaningful weight loss in clinical trials.(1,2) Provided you move to a suitable dose and take the pill correctly, most people can expect to stay on a similar path.
Side effects can be similar across both forms, as they share the same active ingredient. Even so, changing how the medicine is delivered can affect how your body responds, particularly while a new dose settles.
Some people notice small differences in how they feel during this period.
For many people, this is the biggest change to get used to.
With the injection, you pick one day a week and there's little to plan beyond that. The pill works differently, and the timing instructions are strict. To work properly, the Wegovy Pill needs to be taken:(3)
For some people, a daily pill feels simpler than injecting. For others, moving from a flexible weekly routine to a fixed daily one is a bigger commitment than they expect.
It's worth being honest with yourself about which fits your mornings.
If the injection is working well, your side effects are manageable and you don't mind injecting, there may be little to gain from changing.
A pill can sound easier, but the strict timing can be hard to keep up with day after day. Switching may suit you less if your mornings are unpredictable, if you find daily medicines easy to forget, or if you value a more flexible routine.
There's one more thing to weigh up. The injection is also available in a higher strength that the pill doesn't currently match.
If your weight loss has slowed and you may need more support to reach your goal, staying on the injection could give your prescriber more options. Your clinical team can talk this through with you.
The following questions are answered with reference to current guidance on switching between Wegovy injections and the Wegovy Pill. If you have specific concerns about your treatment, please speak to a qualified healthcare professional.
No. You stay on the same active ingredient throughout. You're changing the format, not the medicine, so there's no need for a break in treatment. If you're switching from the weekly injection, you can usually start the pill 7 days after your last injection.
If you're new to Wegovy altogether, you'll need to start on the lowest dose and build up month by month, so your body can gradually get used to the medication. If you're already taking Wegovy, your body is used to Semaglutide, so your prescriber will aim for a strength that reflects your current dose, adjusting if you've been finding side effects difficult.
In many cases, yes. If the pill routine doesn't suit you, this is something to discuss with your clinical team, who can advise on moving back and at what dose.
Both forms have been shown to support weight loss in clinical trials. The most important factors are taking the medicine correctly and being on a suitable dose for you.
Switching from Wegovy injections to the Wegovy Pill is straightforward for many people, but the right choice depends on your current dose, how well treatment is working and whether a daily pill genuinely fits your routine.
There's no single right answer, and there's no rush to decide.
If you'd like help weighing it up, our UK-based clinical team is here to talk it through and support you at every step.
Find out more about the Wegovy Pill and whether switching is right for you, with confidential support from our UK-based clinical team.
You can help monitor the safety of your medication by reporting any suspected side effects through the MHRA Yellow Card scheme.
This page has been written by a registered UK pharmacist and reviewed by our clinical team to ensure it is accurate, clear and reflects current clinical guidance.
Last medically reviewed: 24 September, 2026
Last updated: 26 September, 2026